Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.
Press releases published on May 28, 2025
HCVC leads kyron.bio €5.5M round to use glycan engineering for advanced drug design
GlobeNewswire
·
May 28, 2025
Paris, May 28, 2025 (GLOBE NEWSWIRE) -- One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects. Biotechnology company kyron.bio today announced a €5.5 million funding round to solve these issues …
Alpha Tau to Present at Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
JERUSALEM, May 28, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present at the …
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
GlobeNewswire
·
May 28, 2025
WEXFORD, Pa. and PRINCETON, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- SNAP Biosciences, Inc a majority-owned subsidiary of Coeptis Therapeutics Holdings Inc. (Nasdaq: COEP) and Monarch Therapeutics Inc., a biotechnology company pioneering next-generation …
SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy
GlobeNewswire
·
May 28, 2025
Coverage marks SeaStar Medical’s second award by CMS for reimbursement of medical expenses for Medicare and Medicaid patients in a clinical trial Stands out as rare award with less than 100 clinical trials covered annually DENVER, May 28, 2025 (GLOBE …
Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer
GlobeNewswire
·
May 28, 2025
NEEDHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results
GlobeNewswire
·
May 28, 2025
LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“ …
genXtraits Inc. expands collaboration with The New Zealand Institute for Plant & Food Research Limited to increase vitamin C in crops, including corn and soybean
GlobeNewswire
·
May 28, 2025
ALAMEDA, Calif. , May 28, 2025 (GLOBE NEWSWIRE) -- genXtraits Inc. (genXtraits) today announced that it has expanded its license and collaboration agreement with The New Zealand Institute for Plant and Food Research Limited (Plant …
Design Therapeutics to Participate in 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
CARLSBAD, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will present during the …
A Future Where Women’s Health Leads: The MUHC Foundation Launches $5 Million Movement for Change
GlobeNewswire
·
May 28, 2025
MONTREAL, May 28, 2025 (GLOBE NEWSWIRE) -- Women deserve health care designed with them in mind. They deserve research that includes them, care that reflects their needs, and a future where their well-being is a top priority. Today, on this International …
Un avenir où la santé des femmes est une priorité : La Fondation du CUSM lance un mouvement de 5 M$ pour changer l’avenir des soins
GlobeNewswire
·
May 28, 2025
MONTRÉAL, 28 mai 2025 (GLOBE NEWSWIRE) -- Les femmes méritent des soins de santé pensés pour elles. Elles méritent de faire partie intégrante de la recherche, de recevoir des soins adaptés à leurs besoins et d’avoir accès à un avenir où leur bien-être est …
Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
MONTREAL AND CHARLOTTE, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that Amit Hasija, Chief Financial Officer, and Lorenz Muller, Chief Commercial Officer, will present at the Jefferies Healthcare …
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced the appointment of …
Thumbay Group Launches Thumbay Fergana College of Medical Sciences in Uzbekistan
EIN Presswire
·
May 28, 2025
Admissions are Now Open with limted seats for the Graduate Entry Doctor of Medicine (MD) Program …
Leading Logistics Company Partners with Liveops to Enhance Global Candidate Support Experience
EIN Presswire
·
May 28, 2025
Supporting candidate interactions across the U.S. and Philippines through a blended model to attract top talent, boost efficiency, and reduce costs. SCOTTSDALE, ARIZONA, AZ, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Liveops, the leader in …
BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
GlobeNewswire
·
May 28, 2025
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic …
Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method
GlobeNewswire
·
May 28, 2025
SILVER SPRING, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced the publication of a peer-reviewed article describing the first validated method …
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
ALACHUA, Fla. and TAMPA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Michael Dale, board director, chief …
ABLi Therapeutics Strengthens Leadership Team and Board of Directors
GlobeNewswire
·
May 28, 2025
Directors Appointed from Senior Leadership Teams of J…
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and …
Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism
GlobeNewswire
·
May 28, 2025
Target enrollment exceeded with 62 participants enrolled, including approximately 15 percent from U.S. sites Topline data is anticipated in December of 2025 REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or …